Cargando…
Advances in management of pediatric chronic immune thrombocytopenia: a narrative review
Immune thrombocytopenia (ITP) is a disease in which thrombocytopenia occurs because of immune-mediated platelet destruction and decreased platelet production. Although many pediatric patients with ITP experience spontaneous remission or reach remission within 12 months of first-line therapy, approxi...
Autor principal: | Lee, Jae Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Yeungnam Medical Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390280/ https://www.ncbi.nlm.nih.gov/pubmed/36617702 http://dx.doi.org/10.12701/jyms.2022.00745 |
Ejemplares similares
-
Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review
por: Agarwal, Nikki, et al.
Publicado: (2021) -
Delayed treatment-free response after romiplostim discontinuation in pediatric chronic immune thrombocytopenia
por: Lim, Hyun Ji, et al.
Publicado: (2020) -
The role of romiplostim for pediatric patients with immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2020) -
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019) -
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
por: Nomura, Shosaku
Publicado: (2016)